A Gut Health Crisis:
Impact of GLP-1 Medications on Digestive Wellness, and What You Can Do To Stop It
Amy Rawls, MS, RD, LD, FMNS, CGN
As many as 85% of patients on GLP-1 medications experience significant gastrointestinal disruption and nutritional deficiencies. Digestive support is crucial to these individuals. Managing the gastrointestinal system and providing nutritional education is essential for patients to achieve and sustain their desired outcomes.
In this webinar, we demonstrate how you can properly navigate GLP-1 medication's side effects using our Thrive in 63 program and share the findings of our case study presented at the 2025 NANP convention, The Impact of GLP-1 Receptor Agonist and Digestive Enzyme Supplementation on Gut Microbiome and Metabolic Markers in Obesity Management.
LEARNING OBJECTIVES
In this webinar, we demonstrate how you can properly navigate GLP-1 medication's side effects using our Thrive in 63 program and share the findings of our case study presented at the 2025 NANP convention, The Impact of GLP-1 Receptor Agonist and Digestive Enzyme Supplementation on Gut Microbiome and Metabolic Markers in Obesity Management.
LEARNING OBJECTIVES
- What GLP-1 is, what affects its natural production, how GLP-1 agonists work, their side effects, and their impact on the pancreas and digestive organs.
- Research on how GLP-1 influences body mass, nutritional status, and the microbiome.
- Gaps in current GLP-1 guidance, shared natural ways to boost GLP-1, and how to support the body when using GLP-1 agonists.
- Debunk myths about enzymes and explain why they're essential in any weight loss protocol, especially with GLP-1 use.
- Our latest case study on how GLP-1 agonists and Transformation’s Healthy Gut Program affect the microbiome and metabolic markers in obesity.
Additional Resources
About the Speaker
Amy Rawls has practiced in the Beaumont and Houston area since 2010 when she completed her Master's degree with a Dietetic residency through Lamar University and has gone on to earn additional certifications as a Functional Medical Nutritionist and Certified Gastrointestinal Nutritionist. She has a personal mission to create awareness that even healthy food can be poison if not digested properly, and her passion for health focuses on holistic, integrative, and functional medical nutrition therapy. Amy has spoken at various events, seminars, and conferences both locally and internationally on topics related to nutrition and enzyme application.
About the Webinar Host:
Transformation Enzyme Corporation is a nutritional supplement company specializing in the development of high quality digestive and systemic enzyme, probiotic, and enzyme-delivered nutritional support products. Transformation™ was founded by DicQie Fuller, Ph.D., Dr.Sc., ND, CNC, in 1991 and remains clinically owned and operated to this day. As a leader in mycelial enzyme research, Transformation™ uses every available resource to stay on the leading edge of clinical nutritional science. With 30 years of education and research and an advisory board of clinicians, researchers, educators, and industry leaders guiding us, we are considered the pioneers of enzyme nutrition. For more information visit www.transformationenzymes.com
Transformation Enzyme Corporation is a nutritional supplement company specializing in the development of high quality digestive and systemic enzyme, probiotic, and enzyme-delivered nutritional support products. Transformation™ was founded by DicQie Fuller, Ph.D., Dr.Sc., ND, CNC, in 1991 and remains clinically owned and operated to this day. As a leader in mycelial enzyme research, Transformation™ uses every available resource to stay on the leading edge of clinical nutritional science. With 30 years of education and research and an advisory board of clinicians, researchers, educators, and industry leaders guiding us, we are considered the pioneers of enzyme nutrition. For more information visit www.transformationenzymes.com